Sukhatme Mayukh sold ROIV
December 17, 2025 · Form 4 insider transaction
Sukhatme Mayukh sold 26,831 shares of Roivant Sciences Ltd. at $23.09 per share, a transaction worth $619.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
26,831
Price
$23.09
Total value
$619.5K
InsiderSukhatme Mayukh
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateDecember 17, 2025
Filing dateDecember 19, 2025
Shares owned after18,869,229
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
All options exercised by the reporting person would have expired in March 2026 if not exercised. The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.